Showing results 5 to 8 of 8
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
HBV PGRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued nrti treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study Proceeding/Conference:Oral presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
Report of a study on IMRT planning strategies for ethmoid sinus cancer Journal:Strahlentherapie und Onkologie | 2002 | ||
Safety and efficacy at 1 year after switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in chronic HBV patients with risk factors for TDF use Proceeding/Conference:Journal of Hepatology | 2018 | ||
2021 |